Todd Druley
Year elected: 2019
Current membership category: Active
Chief Medical Officer
ArcherDX, Inc.
4230 Maryland Ave
Saint Louis, MO 63108
United States of America
Phone: 314-807-4936
Email: tdruley@archerdx.com
Website: http://druleylab.wustl.edu

Biographical statement

Todd Druley is the Chief Medical Officer for ArcherDX, Inc and an Associate Professor of Pediatrics, Developmental Biology and Genetics at Washington University School of Medicine. He obtained a Bachelor’s in Cell and Structural Biology and a minor in Chemistry from the University of Illinois. He then completed the MD/PhD program at the University of Illinois where he studied mechanisms of chemotherapy resistance. In 2002, Dr. Druley joined Washington University as a pediatric resident and has remained; completing his fellowship in Pediatric Hematology and Oncology and joining the faculty in pediatric hematology and oncology in 2008. Clinically, Druley established and directs the Pediatric Cancer Predisposition Program. Scientifically, the Druley lab has focused on abnormal childhood development and pediatric cancer as well as genomic methodology development and application to complex disease. In 2019, Druley moved to part-time status at Washington University, keeping his academic lab, but taking a new challenge as the Chief Medical Officer for ArcherDX, which specializes in democratizing high-throughput, molecular barcoded nucleic acid sequencing for research and molecular diagnostics. 

Institutional affiliations

Washington University School of Medicine in St. Louis (Primary)
Deborah J. Veis, MD, PhD is the representative at this institution.

Specialties

Biotechnology
Cancer Biology
Cancer Genetics
Developmental Biology
Genetics
Genomics
Hematology
Medical Genetics
Medical Oncology
Medicine
Molecular Biology
Oncology
Pediatrics